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Objective: Recent evidence has demonstrated that the COVID-19 pandemic is taking
a toll on the mental health of the general population. The psychological consequences
might be even more severe for patients with special healthcare needs and psychological
vulnerabilities due to chronic diseases, such as multiple sclerosis (MS). Thus, we
aimed to explore the psychological impact of this pandemic and of the subsequent
healthcare service changes on young adults with MS living in Italy and to examine their
coping strategies and preferences regarding psychological support in the aftermath of
the pandemic.
Methods: Data were collected using a cross-sectional, web-based survey advertised on
social networks. We report both quantitative (descriptive statistics, t-tests, and one-way
ANOVA) and qualitative data (inductive content analysis).
Results: Two hundred and forty-seven respondents (mean age 32 ± 7 years),
mainly with relapsing–remitting MS, from all Italian regions participated. Participants
felt more worried, confused, sad, and vulnerable because of the disease “during”
the pandemic in comparison to their self-evaluation of the period “before” the
COVID-19 outbreak. Similarly, their perception of control over MS decreased “during”
the pandemic in comparison to the retrospective evaluation of the period “before” the
COVID-19 outbreak (p < 0.01). Canceled/postponed visits/exams were listed as the
most frequent MS management changes, with modified/postponed pharmacological
treatment representing the most stressful change. Psychological support in dealing with
pandemic-related fears and improving MS acceptance and well-being was considered
extremely important by almost 40% of the respondents. Different coping strategies were
mentioned in the qualitative section of the survey, with social support, hobbies, and
keeping busy being the most frequent ones.
Conclusions: Considering the enormous impact of the pandemic on young adults
with MS, we urge MS clinical centers to implement psychological support programs
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that address the potentially long-lasting psychological negative impact, thus fostering
the therapeutic alliance that is being threatened by the infection prevention measures
imposed during the pandemic, and promoting psychological resources for adaptively
managing future waves of COVID-19.
Keywords: pandemic, COVID-19, multiple sclerosis, resilience, psychological adjustment, coping strategies,
psychological support
INTRODUCTION
Multiple sclerosis (MS) is themost common chronic neurological
disease causing disability in young adults. Relapsing forms are
characterized by acute/subacute onset of neurological symptoms
followed by complete or partial recovery and subsequent periods
of relative well-being, whereas in the progressive forms, the
disease shows a worsening of neurological symptoms with an
increase in disability independent of relapses (1). In addition to
the possible physical limitations due to neurological symptoms,
MS patients experience psychological distress and are at higher
risk of depression and anxiety compared to the general
population (2–4). Since MS is generally diagnosed in a stage of
life of great significance for the achievement of personal goals
(i.e., between the ages of 20 and 40) (5, 6), the adaptation to this
chronic disease, especially in the first years after MS diagnosis,
may become even more emotionally challenging (7–12).
It is widely recognized that MS pathogenesis is driven
by an immune system dysregulation targeting the central
nervous system (13, 14). For this reason, currently available
disease-modifying therapies are represented by drugs with
immunomodulatory and/or immunosuppressive mechanisms of
action, which may significantly ameliorate the disease course (15,
16).While this is clearly reassuring for patients and clinicians, the
potential risk of adverse events may be worrisome, particularly
in situations of vulnerability. In routine clinical practice of many
countries, patients with MS regularly access the outpatient clinic
both to check their clinical status and to monitor the effectiveness
and safety of ongoing treatment; the frequency of visits depends
on patient age and disability, disease characteristics, and therapy.
Typically, each MS patient contacts or accesses a specialized
clinical center multiple times a year (17).
In December 2019, a respiratory infection (i.e., COVID-19)
caused by a novel coronavirus, namely, severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), was detected in China
and rapidly spread worldwide in the following weeks, causing
soon a pandemic (18). Italy has been one of the first and
most severely affected countries outside China (239,410 infected
people with 34,644 deaths as of June 24 2020—Istituto Superiore
di Sanità) (19), leading the Italian government to initially
declare the state of emergency starting from January 31, 2020,
and, subsequently, from the end of February, to implement
progressive restrictions of movement culminating in the country
lockdown imposed from March 10 to May 3 2020, followed
by a gradual lifting of these measures in the months of May
and June 2020. The emergency due to the COVID-19 pandemic
has significantly impeded the regular access of patients to MS
centers. Indeed, among other restrictions, the health security
measures taken by the Italian Government to contain the spread
of infection imposed the suspension of non-urgent care (20).
To ensure continuity of care and treatment for MS patients,
clinicians opted for alternative communication strategies, such
as telemedicine tools (e.g., emails, phone calls, and videocalls)
(21–23).
Recent studies have highlighted the psychological burden of
the COVID-19 pandemic, including high prevalence rates of
psychological symptoms and disorders, with potentially long-
lasting effects (24–26). As indicated by previous experience
during the 2002/2003 severe acute respiratory syndrome
coronavirus epidemic, psychological interventions could be a
favorable option also for chronic patients to deal with the adverse
psychological impact (27). However, to the best of our knowledge
and at the moment of preparation of the current paper, studies
exploring the psychological impact of the COVID-19 pandemic
on patients with MS are still sparse. Those articles do not
explore specifically the changes in patients’ disease perceptions or
expectations on psychological support (28–33). Moreover, none
of these articles integrated quantitative and qualitative methods.
To fill this gap, the aims of this explorative study were 4-
fold: (i) to describe the potential psychological impact of the
COVID-19 pandemic on MS perceptions of young adults with
MS, (ii) to examine changes in themanagement of the disease and
the provision of health services and their perceived stress linked
to those changes, (iii) to explore their preferences in terms of
psychological support, and (iv) to explore their coping strategies
in facing the pandemic consequences.
To achieve these aims, qualitative and quantitative methods
have been synergically applied. In particular, a quantitative
approach has been applied for the first three aims and a
qualitative one for the latter. We assumed an increase of negative
emotions regarding MS and of the sense of vulnerability and a
reduction in control perception over MS due to the pandemic,
a high level of perceived stress linked to the changes in the
management of MS regarding different aspects of MS care.
Further, we supposed that young adults with MS would consider
psychological support highly relevant.
METHODS
The study is part of a larger project (ESPRIMO project), a
prospective program aiming to study and promote resilience in
young adults with MS. This general objective will be pursued
through the activation of a working group that will involve,
in the different phases of the program, the main stakeholders:
health professionals (e.g., neurologists, psychologists, nurses, and
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rehabilitators), researchers from multiple disciplines related to
basic research and applied research, MS patient associations (e.g.,
local Italian Multiple Sclerosis Association), patients with MS,
territorial bodies (e.g., municipality), and private entities (e.g.,
foundations). The team is coordinated by a group of clinicians
from the Regional Multiple Sclerosis Center of the Borgo Roma
Hospital of the Integrated University Hospital of Verona and
researchers from the Department of Neuroscience, Biomedicine
and Movement of the University of Verona, engaged in care and
research activity in the field of MS for many years. The final
goal of the project is to develop and evaluate the effectiveness
of a biopsychosocial intervention that promotes resilience and
adaptation to the disease to increase quality of life in young
adults with MS. The project was activated in 2018 as part of the
departmental development program “Behavior and well-being:
a multidisciplinary approach to promote the quality of life in
conditions of vulnerability” of the Department of Neuroscience,
Biomedicine and Movement of the University of Verona funded
by the Ministry of Education, University and Research. The
two core elements of the ESPRIMO project are the BPS-ARMS
study and the ESPRIMO feasibility study. The first study aims
to explore the resilience and quality of life of young patients
by adopting a biopsychosocial approach, that is, by studying
the possible clinical, biological, social, and psychological factors
connected to adaptation and resilient reaction to disease event in
patients at onset. The second study will last 24 months, following
three main consequential phases: the initial co-creation phase
aiming to develop a biopsychosocial intervention (the so-called
ESPRIMO intervention) targeted at young adults with MS; the
intervention phase aiming to test preliminary effect, feasibility,
and acceptability of the ESPRIMO intervention in a sample of
young patients with MS; and the third phase aiming to fine-tune
the ESPRIMO intervention.
As part of the project “ESPRIMO,” the present study has
been approved by the Ethical Committee of the Verona
Hospital (Prog. 2676CESC) and registered on ClinicalTrials
(ClinicalTrials.govID: NCT04431323). The study uses a cross-
sectional, observational design and followed the STROBE
checklist (34).
Data were collected between May 13 and June 3, 2020, using
a web-based, anonymous survey. Young adults with MS, being a
resident of Italy during the COVID-19 pandemic, and meeting
the following inclusion criteria could participate: age 18–45
years, MS diagnosis, Italian speaker, and electronic informed
consent signed.
According to the ESPRIMO project, the definition of the age
range for “young adults” from 18 to 45 years is made on the basis
of the clinical onset of MS and course of the disease. Indeed, it
has to be noticed that a clear age cut-off for the definition of
“young adult” has not been established in the medical field, and,
as discussed in a previous paper in the field of neurology in Italy,
an age cut-off might be considered arbitrary (35). In our case,
the age range has been defined on the basis of the age range
of MS onset (i.e., 20–40 years), extending the age of inclusion,
setting the minimum age to 18, and widening the maximum age
to 45. MS is a chronic disease and typically long clinical course
leading to a relevant group of patients reaching elderly with the
disease. Consistently, Garcia and Finlayson (36) defined people
from the age of 45 as “aging withMS”. Therefore, we focused on a
subgroup of MS patients who could be considered “young” given
the disease history.
The survey was advertised on the Facebook page and the
Instagram profile of the ESPRIMO project as well as in several
Facebook groups focusing on MS. The advertisement also
encouraged people to share the survey link to others who are
potentially eligible. Electronic informed consent was obtained
from all participants prior to data collection.
Survey
We created an ad hoc, self-administered questionnaire composed
of closed and open questions, divided into four sections aiming
to explore the following topics: psychological impact (section
1 and section 2b), changes in MS management (section 2a),
preferences regarding psychological support (section 3), and
psychological resources (section 4) (Appendix 1). Moreover,
some sociodemographic and clinical data have been collected.
The psychological impact of COVID-19 has been
quantitatively explored in section 1: self-reported perceptions
about the MS regarding emotions, illness perception, and
commitment to deal with MS before and during the pandemic.
Since the existing brief and validated questionnaires were
not able to explore all these specific areas, we created an ad
hoc scale, composed of seven items evaluating the following
MS perceptions on two 10-point Likert scales (i.e., before the
COVID-19 emergency and during the COVID-19 emergency): a
range of feelings about the MS disease (i.e., anxiety, confusion,
sadness), illness perceptions (i.e., vulnerability, control over
illness), and commitment to deal with MS (i.e., commitment
to manage the disease and to seek social support). The analysis
of the Cronbach alpha considering these seven items indicates
a high reliability for the two considered time frames (before
COVID-19= 0.81 and during COVID-19= 0.84).
The second section explored both (a) changes in the services
offered by clinical centers (e.g., medical visits, psychological
visits, pharmacological treatment, and telemedicine) and (b)
psychological impact in terms of perceived stress linked to
the changes in MS care. When answering to this question,
respondents could pick up more than one change and also add
other changes not listed in the questionnaire. Stress was assessed
using a 10-point Likert scale, ranging from 1 (“no stress”) to 10
(“maximum level of stress”).
Moreover, a third section explored needs and preferences
regarding psychological support of young adults with MS.
Finally, the fourth section qualitatively investigated
participants’ psychological resources (namely: coping strategies,
helpful/positive thoughts and learnings). In the present study, we
will focus on coping strategies, defined by Lazarus and Folkman
(37) as “constantly changing cognitive and behavioral efforts
to manage specific external and/or internal demands that are
appraised as taxing or exceeding the resources of the person”.
Coping strategies were investigated by asking the following
question: “Please complete the following sentence: The strategy
that has proven most useful for getting through this pandemic
period has been...”
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The survey has been implemented using the software
LimeSurvey, an open source online tool that allows to develop,
publish, and collect responses to surveys.
Data Analysis
Statistical Analysis
Descriptive statistics were presented as mean values and standard
deviation (SD) for continuous variables and as absolute and
relative frequencies for categorical variables. A set of Student’s
paired t-tests were applied to compare participants’ levels of
negative emotions, illness perception, and commitment to deal
with MS before and during the pandemic. Student’s two-group t-
tests and one-way ANOVA were used to explore the differences
across the main sociodemographic variables (see Tables 1–5 in
Appendix 2; gender differences have been explored only on a
sub-sample of participants).
A choropleth map, showing the spatial distribution of
respondents among the Italian regions, was drawn with the Stata
package grmap. All the analyses were performed with STATA 15.
Inductive Content Analysis
Participants’ answers to the open question on coping strategies
were grouped in an Excel file. Two researchers (AGh and VD)
independently analyzed all answers and created a list of possible
labels. Interrater reliability had good results: the percentage of
agreement was 90% (CI 86–94%), Krippendorff ’s Alpha 0.88
(CI 0.84–0.93). These labels were then compared in a plenary
meeting, and concordant and discordant labels were discussed
with a third reviewer (MR). As a next step, all answers were
coded using the finalized labels. Answers containing more than
one type of coping strategy were divided into different utterances
and coded separately. Frequencies of different types of coping
strategies are reported.
RESULTS
Sociodemographic Characteristics of the
Sample
Of the 368 young adults with MS who accessed the survey, 67
were excluded according to the exclusion criteria (i.e., 14 for
age, 53 not giving the consent). Furthermore, 52 of the surveys
were returned empty or with only sociodemographic information
compiled and 2 were compiled by residents abroad during the
pandemic and thus excluded from further analysis, leaving a total
sample of 247 respondents included in the analysis.
Respondents reported a mean age of 32 years (SD = 7)
covering all possible ages (i.e., 18–45 years); 44% of respondents
were 18–30 years old. Of all respondents, 46% were married or
living with a partner, 55% were occupied, and 44% presented at
least an academic degree.
Regarding the place of residence during the COVID-19
pandemic, surveys were completed in all Italian regions, with 117
(47%) respondents living in the north, 47 (19%) in the center, and
83 (34%) in the south of the country (see Figure 1).
Most respondents reported a diagnosis of relapsing–remitting
MS (227; 92%), whereas 7 (3%) had primary progressive MS, 8
FIGURE 1 | Map of the respondents’ frequency distribution by regions
(n = 247).
(3%) had secondary progressive MS, and 5 (2%) had clinically
isolated syndrome (CIS).
Emotions Regarding MS, Illness
Perceptions, and Commitment to Deal
With the Disease Before and During the
COVID-19 Pandemic
Table 1 summarizes patients’ emotions, illness perceptions, and
commitment to deal with the disease before and during the
pandemic and the impact of COVID-19, calculated as the
difference between the values expressed in the two phases
(“during” vs. “before”). The mean levels of anxiety/worry and
sadness/discouragement linked to MS significantly increased
during the pandemic (p < 0.01). Similarly, respondents were
significantly more confused/disoriented regarding their MS
(p < 0.01). In addition, we found a negative impact of the
pandemic on patients’ illness perception, with a significant
increase of vulnerability perception and a reduction of personal
control over MS (p < 0.01). Conversely, patients were equally
committed before and during the pandemic to find support and
effective strategies to manage the disease.
No significant differences emerged between the two examined
age groups (18–30 vs. 31–45 years) for the changes between
“during” and “before” COVID-19 in self-reported perceptions
about MS. Similarly, these changes did not significantly differ
among subgroups regarding the other main sociodemographic
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1: “How anxious/worried do you feel about the course of your
disease?”
5.4 (2.1) 6.4 (2.3) 1.1 (2.0) 8.7 <0.01
2: “How vulnerable do you feel because of your disease?” 5.6 (2.2) 6.9 (2.5) 1.3 (1.9) 10.8 <0.01
3: “How disoriented/confused do you feel about managing
your disease?”
4.6 (2.5) 5.8 (2.8) 1.2 (2.0) 8.9 <0.01
4: “To what extent do you feel you have control over your
disease/you are able to manage your disease?”
6.2 (2.2) 5.7 (2.3) −0.6 (1.9) −4.5 <0.01
5: “How sad/discouraged do you feel regarding your
disease?”
5.3 (2.7) 6.1 (2.7) 0.8 (1.8) 7.1 <0.01
6: “How much energy have you invested in finding support
and help in managing your disease?”
5.3 (2.8) 5.3 (2.9) −0.0 (1.8) −0.0 0.97
7: “How much energy have you invested in finding effective
strategies to manage your disease?”
6.2 (2.6) 6.1 (2.6) −0.04 (1.8) −0.4 0.69
characteristics or place of living (north/central/south regions of
Italy). See Tables 1–5 in Appendix 2 for a detailed description of
the results for each item.
Changes in Care Management and Related
Perceived Stress
Half of the respondents (n = 123) reported changes in
MS management during the COVID-19 pandemic. Table 2
summarizes results regarding the main changes in the
healthcare process, including medical, psychological, and
physical treatment, as well as pharmacological therapies and
re-organization of services (e.g., telemedicine). Mean levels
of stress attributed to each specific MS management change
are reported as well. Canceled or postponed medical visits or
exams were listed as the most frequent changes, whereas changes
in pharmacological treatment represented the most stressful
change. The general mean score of stress related to the changes
described above was 6.5 (SD= 3; 3rd quartile= 8).
Needs/Preferences Regarding
Psychological Support
Participants rated the importance of psychological support for
young adults with MS in the aftermath of the emergency on a
scale of 1 to 10 with a mean value of 8 (SD= 2; 3rd quartile= 10).
As shown in Figure 2, among the respondents (n = 221),
the majority reported that the psychological intervention should
focus on the reduction of unpleasant emotions and on the
promotion of strategies to improveMS acceptance, tomanage the
fear of being infected and the work/socio-relational changes due
to the pandemic.
Coping Strategies
Two hundred and eleven MS patients (85%) responded to the
qualitative section of the survey, with six being excluded as they
answered “no strategy.” Two hundred and five patients (83%)
described coping strategies in dealing with pandemic-linked
stress and were included in the following qualitative analysis.
TABLE 2 | Changes in medical treatment due to the COVID-19 pandemic and the
related perceived stress (n = 123*).










Canceled or postponed medical visits
or exams
78 6.6
Telehealth services 31 5.9
Canceled or postponed psychological
treatment
19 5.7
*Participants might select more than one change in medical treatment.
Twelve different types of coping strategies were indicated by
respondents as useful to deal with the stress, with social support,
hobbies, and keeping oneself busy being the most applied ones (see
Table 3). It has to be noted that 52 respondents reported more
than one coping strategy.
Table 6 in the Appendix 2 reported percentages of
participants without a worsening of MS perceptions (i.e.,
emotions and illness perceptions) for each coping strategy. Social
support, hobbies, and keeping oneself busy, which are the three
strategies most frequently mentioned as effective by participants,
seem to be associated to lower percentages of worsening in terms
of sadness and disorientation.
DISCUSSION
This cross-sectional study has been conducted in the aftermath of
the first wave of COVID-19 emergency in Italy. Findings allowed
us to make a picture of an understudied population, such as the
one of young adults with MS, regarding the psychological impact
of the pandemic in terms of MS perceptions, changes in MS
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management, and consequent related perceived stress. Moreover,
the main coping strategies evaluated to be useful by young adults
with MS in dealing with the emergency and their perspective on
the relevance of psychological support have been explored.
As regards the first aim of the current study, a higher level of
anxiety, sadness, and confusion about MS emerged during the
pandemic. Although the focus of the survey was on emotions
regarding MS, results seem to confirm the negative impact of
the pandemic on individuals’ mental health, as already suggested
by recent studies in the general population (24–26). As regards
young adults, Liu et al. confirmed symptoms of depression,
anxiety, post-traumatic stress disorder, loneliness, and poor
resilience in adults under 30 years (39). Looking at the whole
Italian context, among the general population, the young adult
subgroup seems to be particularly vulnerable to the COVID-
19 pandemic, as reported by Forte et al. who showed a greater
negative psychological impact on people under 50 years (25).
However, considering the recent publications focusing on
the psychological impact of COVID-19 pandemic in the MS
population, results appear to be more controversial. Indeed,
a study on patients with MS in a southern region of Italy
indicated no increase in anxiety and depression and also some
improvements on quality of life during the first wave of the
pandemic (33), whereas other authors showed a high level of
anxiety (29, 32). However, it has to be noted that, even if
containment and control measures equally applied to all Italian
regions during the period of the current study, the risk of
contracting COVID-19 varied across Italy, and, as recognized by
the Capuano et al., their contrasting results might be explained
also by the fact that during the first wave, the southern regions of
Italy were much less affected by the COVID-19 epidemic (33).
However, to consider the national differences in pandemic
spread, which may have led to varying degrees of perceived
risk and uncertainty among respondents, depending on area
of residence, and, additionally, the potential differences in
organization and delivery of MS health services, which might
be different across the various MS centers, a comparison of
changes in MS perceptions among survey participants living in
the northern, center, or southern regions has been conducted,
resulting in no differences. Similar to our results, the recent study
of Forte et al. (25) assessing different measures of psychological
impact found significant differences between the north, center,
and south of Italy only for sleep disturbances.
Moreover, a similar worsening in emotions and illness
perceptions linked to MS emerged when considering both young
adults under 30 years or the ones in the 31–45 age range and other
sociodemographic characteristics.
The increase of anxiety, sadness, and confusion is consistent
with the theme of uncertainty, which might be considered a
common feeling that characterized the experience of people
during the pandemic, due to the novelty of the emergency,
severe symptoms, high mortality rates, lack of cure, the
severe consequences for daily life and society, and the
highly unpredictable future course of the pandemic (25, 40).
Uncertainty is a familiar psychological construct for people who
have to live with chronic illness. Indeed, due to the complexity
and unpredictability of clinical course and potential treatment
side effects, people with MS have to accept in their adaptation to
illness and chronicity that not all the aspects of their health can be
controlled and foreseen (41–43). In line with this evidence, our
results suggest that the public health emergency has negatively
influenced MS perceptions for young adults with MS, leading to
an increased sense of vulnerability and lack of control over MS.
As regards our second aim, half of the respondents highlighted
at least one change in the MS management due to the COVID-19
pandemic. Although respondents indicated an overall moderate
level of perceived stress, 44% considered these changes as severe
(i.e., 8–10 on the 10-point Likert scale). The high relevance
of MS management changes is consistent with a previous
research, highlighting the fact that patients with MS in Saudi
Arabia reported a significant impact of the pandemic on their
MS healthcare, in particular due to fear of being infected
(44). Although canceled or postponed medical visits or exams
have been, according to the participants’ perspective, the most
frequent change in MS management, the modified or postponed
pharmacological treatment had the worst impact on perceived
stress. Though we did not explore this relationship in our
analysis, we might hypothesize that changes in routine clinical
procedures, a reduced number of encounters with healthcare
professionals, and the postponement of care and the associated
perceived stress might have also contributed to uncertainty and
thus the reduced level of perceived illness control and increased
vulnerability perception. To support this consideration, a recent
Serbian study reported the impossibility to go to hospital as usual,
the difficulties in drug availability, and the worsening of the
MS status in case of contagion as the main concerns regarding
relapsing–remitting MS during the pandemic outbreak. During
the pandemic, the use of telemedicine and digital services has
been widely extended to compensate for the reduction of services
provided in person. As previously suggested, telemedicine should
be offered in order to effectively respond to the needs of MS
patients in times of emergency, such as the COVID-19 pandemic
(21, 23, 45). Moreover, considering the high use of web and
mobile applications by young adults, e-health resources, aiming
to provide strategies and support in dealing with stress and
emotions linked to the pandemic, might be especially useful.
Indeed, as regards our third aim, almost 40% of the respondents
rated as extremely important (i.e., 10 on Likert scale) the
opportunity to receive psychological support, stressing not only
the support in dealing with emotions and MS acceptance in
general but also in managing the fear of being infected.
Looking at the last explorative aim, our respondents seemed
to adopt a wide range of coping strategies to deal with the
stress linked to the COVID-19 emergency. Overall, looking to
the variety of coping strategies, the most frequent strategies
evaluated as useful in patients’ eyes were social support, hobbies,
and keeping oneself busy. Results are quite different from what
was observed in a previous study where active coping and
religion were the strategies most frequently adopted in order to
face COVID-19 (31). Conversely, the relevance of those coping
strategies, which emerged in our study, was consistent with
other results reported during the COVID-19 pandemic and,
more in general, in the chronic disease field, as discussed in the
section below.
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FIGURE 2 | Topics that should be addressed in psychological support programs, by relevance.
The evaluation of social support as one of the main coping
strategy in dealing with the pandemic is coherent with the
consideration that, in general, perceived social support and
positive relationships are associated with better MS adjustment
(41). Consistently, in the other Italian study mentioned above,
authors highlighted that patients during the pandemic might
have experienced a higher social support (e.g., more opportunity
to spend time with family members) that could have been
associated to the absence of worsening in depressive symptoms
(33). Similarly, a recent survey assessing US young adults
during the COVID-19 pandemic reported that family support is
associated with low levels of psychological symptoms (39). The
category “social support” contained not only respondents’ quotes
regarding the support received by others but also the support they
provided to relevant people during the pandemic, thus suggesting
that in challenging or even threatening situations, connection
and empathy among relatives and friends might play a significant
role in protecting from perceived stress.
Interestingly, among the most frequently useful coping
strategies, we also found pleasant and meaningful activities in
everyday life that mostly rely on personal internal resources
(i.e., hobbies), suggesting the beneficial power of engaging in
value-consistent actions that stimulate creativity (e.g., cooking,
painting) and personal growth (e.g., reading). Similarly, physical
activities and meditation/relaxation also emerged as relevant
strategies for respondents’ personal well-being.
“Keeping oneself busy” was also frequently considered as
effective by young adults with MS. A similar result emerged
in Umucu and Lee (46), who highlighted self-distraction with
other activities as one of the most frequent coping strategies
with COVID-19 among participants with chronic conditions
and disability. As reported in a previous study in the context
of chronicity, this strategy might have a controversial role in
terms of adaptiveness (47). In general, we might assume that if
it is applied to deny stress and avoid any stressors, it can be
maladaptive for emotion regulation. In contrast, if it is used to
mitigate uncertainty and fear linked to COVID-19 in the short
period, it might help to preserve a sense of self-efficacy and
control in daily life.
Similar to the study by Umucu et al. who reported
the “tendency to deny the reality of COVID-19” as the
least commonly used strategy, in our sample, “experimental
avoidance” also emerged only in a small number of quotes (46).
Although the survey was not aimed to make a diagnosis of
psychiatric disorders or identify patients with high risk of scarce
adaptation to MS, the detected significant negative psychological
impact indicates that this aspect has to become one of the
priorities of clinical centers when restarting routine healthcare
after the emergency phase and during the further wave(s) of the
pandemic. Indeed, unfortunately in Italy, at themoment in which
this paper is under revision, a second wave of the pandemic
is occurring with healthcare services being newly affected by
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TABLE 3 | Applied coping strategies during the time of the pandemic, including examples and frequencies (n = 205).
Type of coping strategy Description Example Number of
quotes
Social support Turning to friends, the partner, family members, children, or
psychosocial support*, using also different types of
telecommunication
• “Cultivating relationships, primarily with my partner, but also
with friends and family (via video calls and messages)”
• “Talking about my fears”
44
Hobbies Finding new hobbies and/or revisiting old ones, including, for
example, reading, gardening, painting, English course,
cooking
• “Starting with new hobbies”
• “Devoting myself to the things that I like but that before I
had no time and way to do”
42
Keeping oneself busy Efforts to stay active and be occupied, in particular with
mental activity and work/studying
• “Focusing on work”
• “Doing and learning new things at home that allowed me at
that time not to think about multiple sclerosis and
various difficulties”
39
Positive thinking Efforts to think positively, including also positive reappraisal
(i.e., attempts to re-construe stressful events as valuable or
useful)
• “Taking advantage of uncomfortable situations to create
something good”





prevent the transmission of
COVID-19
Behaviors that follow the prevention and containment
measures taken by the government and/or the
recommendations given by healthcare organizations
• “Limiting personal movement and contact with others as
much as possible”
• “Taking the necessary precautions without panicking”
24
Physical activity Efforts to be physically active, either at home or outside • “Doing physical activity at home or even better outdoors in
the garden to enjoy also the sunlight”
• “Keeping active, doing exercises”
22
Meditation/relaxation Efforts to relax one’s stressed mind, applying also specific
relaxation techniques, such as meditation and breathing
• “Having done mindfulness exercises was very useful”
• “Thinking of these days as an opportunity to relax”
19
Patience/acceptance Efforts to accept or tolerate one’s circumstances without
becoming annoyed or upset
• “Take the situation with a profound sense of calm”
• “Taking life day by day”
18
Experiential avoidance “Attempts to avoid thoughts, feelings, memories, physical
sensations, and other internal experiences even when doing
so creates harm in the long-run,” (38) including experiences
linked to the pandemic
• “Avoiding to think about risk”





Efforts to stay informed while being selective about news
sources
• “Informing oneself by reading reliable sources”
• “Contacting the AISM (i.e., Italian Association of Multiple
Sclerosis) to receive adequate information”
9
Preserving routines Endeavors to maintain one’s pre-pandemic daily routine • “Keeping a routine with daily goals”
• “Maintaining the pre-COVID routine”
8
Setting/changing priorities Endeavors to set new objectives and priorities and reassess
one’s set of priorities acquired prior to the pandemic
• “Rearranging time and priorities”
• “Considering it as opportunity to have time to restructure
priorities and reorganize the day, doing what I really like
to do”
6
*This category includes two quotes regarding psychosocial support received by psychological services.
reduced visits and changes in MS management. Considering
changes in MS perception and reducing stress linked to changes
in MS management is a priority for healthcare professionals
working in MS field, not only because it is strictly linked to
patients’ global well-being but also because it has implications for
patient empowerment in illness management. Indeed, emotional
dimensions interact with risk appraisal, rational thinking, and
decision-making, key elements that influence health decisions
and proactive behaviors in chronic illness (48). Considering
the increased level of vulnerability perception and reduced
control over the disease, and the continuous uncertainty linked
to the further actual spread of the pandemic, psychological
interventions, also through telemedicine, should reinforce the
therapeutic alliance and continuity of care through empathic
and supportive listening. Specifically, as part of a larger project
ESPRIMO, results derived from this explorative survey will
contribute to inform the development of the specific ESPRIMO
biopsychosocial intervention aiming to promote resilience and
health-related quality of life in young adults with MS and,
more broadly, enhance patients’ adaptation to MS. Indeed,
the ESPRIMO intervention should not avoid to also address
the potentially long-lasting negative psychological impact and
MS management changes caused by the COVID-19 pandemic
on this particularly vulnerable clinical population. This also
considers that the target population is in the age range of
onset of the disease, a period especially difficult for the
psychosocial adjustment to the disease (9). On the basis
of the current results, the psychological component of the
intervention should also foster strategies to better deal with
the fear of being at risk of being contagious for COVID-
19 and to reduce the sense of vulnerability and the stress
linked to the uncertainty and to changes in MS management
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and everyday life. The group modalities will characterize the
intervention and should favor a shared expression of the COVID-
19 experience to foster a sense of acceptance, belonging, and
security and potential releases of psychological impact of the
pandemic together with the interpersonal learning on useful
coping strategies.
Strengths and Limitations
Over the past months, several studies have provided important
information on the psychological impact of the COVID-19
pandemic on the general population, healthcare professionals,
and some clinical populations, and, more recently, some
articles have also explored its impact on MS populations.
However, our study presents some novelty aspects that
make it unique: exploring the negative effects of the
current pandemic specifically for young adults with MS;
focusing on the emotions, perceptions, and commitment
specifically linked to MS; and using both quantitative and
qualitative methods.
Recruiting adults with MS within the ages of 18 to 45 allowed
us to explore a group that is particularly vulnerable in terms of
adjustment to live with the disease, which is often diagnosed in
this age range.
The open qualitative exploration of patients’ perspective
on self-perceived functional coping enabled us to capture a
wide, genuine, and heterogeneous description of all the coping
strategies applied during the pandemic by patients, in order
to face the risk of infection and their disease. This is in line
with our adoption of a resource-based approach oriented to
raising and valuing patients’ awareness of personal strategies.
As previously highlighted, this qualitative approach allowed
us to explore an aspect still little investigated, especially in
the period when we performed the survey, which was during
the first wave of the pandemic when the first priority was to
detect emerging psychological needs in the population subject
of our clinical interest not making a priori assumption on
their coping style. By giving to participants the possibility of
reporting their own strategies, we recognize the patients’ role
as experts; patients feel reassured and motivated in this way
and therefore free to report about their own experience, without
the fear of saying “something wrong” (49). Future psycho-
educational or supporting interventions, based on suggestions
provided by peers on the basis of their own real experiences
during the first wave of COVID-19, might represent a
particularly valuable resource for patients facing further waves of
the pandemic.
Furthermore, using online modality for our survey was
appropriate considering the explorative nature of the study but
presents both limitations and strengths. As regards limitations,
the fulfillment of inclusion criteria was self-evaluated by
participants, thus limiting the control on the sampling and
potentially the accuracy of the answers. As regards strengths,
using online modality guaranteed safety in the aftermath of
the COVID-19 pandemic; had the ability to reach a larger
pool of potential participants within a shorter period of time,
reducing costs and improving efficiency of data collection
and management; allowed the recruitment of patients from
the whole of Italy, including patients otherwise difficult to
approach; and provided improved comfort and sense of control
for participants (50, 51). Moreover, it has to be considered
that social media represented an especially powerful tool to
recruit our specific sample, since it is known to be a very
popular channel of interaction for young adults (52). As
regards the second aspect, it has to be considered that by
advertising the survey among online MS groups, we reached
mainly patients already involved in MS management and
probably missed more isolated patients, who might represent
also the most vulnerable group. Moreover, in terms of
generalizability, considering that almost all the respondents
reported a diagnosis of relapsing–remitting MS, our study did
not sufficiently capture the psychological impact and needs of
patients with different types ofMS during COVID-19 emergency.
Moreover, given that participation was voluntary, it might be
assumed that patients more interested in psychological topics
were more likely to participate, thus leading to a potential
selection bias.
A strength lies in the comparison of patients’ emotions
regarding MS, illness perception, and commitment to deal with
MS before and during the pandemic. Although a specific time
frame is difficult to define and might vary subjectively since
the spread of COVID-19 varied across Italian regions, the
survey has been conducted in the aftermath of the first wave
of the pandemic, and in answering, patients refer to a period
characterized by major quarantine policies in place (e.g., severe
restrictions of movement, reduced outpatients visits in most of
the public and private hospitals, complete or partial shutdowns
of economic and social activities) and a widespread perception
of high risk due to the large numbers of reported cases and
deaths. Although this methodology has been previously used
in another Italian paper on COVID-19 (25), it must be noted
that participants’ retrospective self-reports might be influenced
by recall bias, thus potentially influencing the perception of the
participants and the validity of our findings. Therefore, the lack
of a proper longitudinal design for evaluating the psychological
impact represents one of the main limitations of the study.
Moreover, we preferred to create an ad hoc scale for this specific
aim of the study, which showed high reliability. However, the
scale was not validated.
The fact that our sample covered all the Italian regions
represents an additional strength, as previously reported being
able to collect data from areas with different degrees of
transmission. Indeed, the only previous study that considered
the psychological impact of the pandemic on patients with MS
in Italy was based on a relatively small sample size of patients
living in a specific region in the south of Italy. However, regarding
the sociodemographic and clinical information explored in the
survey, some weakness has to be highlighted too; in particular,
the exploration of gender was limited to just a low percentage
of our participants. Moreover, we did not assess and consider if
participants or their family members were actually exposed to
the virus and got infected. Therefore, future studies are needed
in order to deepen the role played by sociodemographic and
clinical characteristics on the psychological impact of COVID-19
within chronicity.
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CONCLUSIONS
Tackling the psychological impact of COVID-19 international
emergency and of the consequent changes in healthcare
organizations aimed to reduce the risk of disease transmission
should be a top priority for MS clinical centers that are
striving for continuous improvement. Psychological support
programs tailored to patients’ individual psychological needs and
preferences would help to strengthen the therapeutic alliance
that has been threatened by the infection prevention measures
imposed during the pandemic and to foster patients’ capacity for
adaptation and “bouncing back” in the face of significant sources
of stress [i.e., resilience (53)] such as the COVID-19 experience.
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